Introduction
The Gram-positive pathogenic bacterium Streptococcus pneumoniae is the major causative agent of bacterial pneumonia, besides causing meningitis, sinusitis, acute otitis media and septicemia, thus leading to high morbidity and mortality in young children and the elderly throughout the world [1] . As seen with most bacterial pathogens, S. pneumoniae uses its surface proteins in the process of infecting its host [2] . These proteins are mainly a diverse group of surface adhesins and invasins, that promote attachment to and mediate invasion of the epithelial cells of the host respiratory tract and lung surfaces, by binding specifically to the host cells and targeting components of the extracellular matrix (ECM), leading to colonization [2, 3] . Some of the pneumococcal surface proteins that are characterized include hyaluronan lyase, pneumococcal surface proteins A and C (PspA and PspC), fibronectin (Fn)-binding pneumococcal adherence and virulence factors (PavA and PavB) and choline-binding proteins (CbpA and CbpE) [4] . A few other adhesins and invasins are pneumococcal surface adhesin A (PsaA), enolase, polyhistidine triad (Pht) proteins, plasmin(ogen)-and Fn-binding protein A (PfbA), pneumococcal serine-rich repeat protein (PsrP) and neuraminidases (NanA and NanB) [3] . Host molecules targeted by the adhesins are proteins present in the ECM like collagen, laminin, elastin, Fn and plasminogen among others [2, 5, 6] . In the wake of the serotype-dependency of the currently used polysaccharide-based and conjugate vaccines, as well as the emerging resistance of S. pneumoniae to existing antibiotics [3, 5] , understanding the molecular basis of the host-pathogen interactions mediated by these surface proteins which are virulence factors, would pave the way for producing novel therapeutic agents against S. pneumoniae.
Plasmin(ogen)-and Fn-binding protein A (PfbA) has the N-terminal signal sequence and the C-terminal cell-anchoring sequence motif, 'LPxTG' (Fig. 1A) and is localized to the cell surface of S. pneumoniae [5] . It is one of the vaccine candidates as it facilitates S. pneumoniae to adhere to, colonize and invade the epithelial cells of the upper respiratory tract, lungs and larynx of the host and thus establish infection [5] . PfbA does so by interacting with and binding to host proteins like plasmin(ogen) and Fn [5] . PfbA also protects the bacterium from the host immune system by providing it resistance to phagocytosis, in addition to its ability to adhere human serum albumin (HSA) [5] . PfbA, which is found to be conserved among all sequenced pneumococcal strains, is thus envisaged as an important adhesin in arbitrating pneumococcal-host interaction [6] . Crystallographic and small angle X-ray scattering (SAXS) studies revealed that PfbA has an elongated overall structure with three modules or domains, and its 422-residue central module is in the form of a right-handed 12-stranded parallel beta helix (PDB ids: 3ZPP; 4MR0) [6, 7] (Fig. 1A,B) . Its structure is analogous to those of carbohydrate-active enzymes (CAZymes) like polysaccharide lyases and glycoside hydrolases [6] . The beta helix domain possesses a distinct groove, which is the conserved substrate-binding site in all the CAZymes, running the length of its face [6] . However, according to the experiments carried out by Suits and Borasten, PfbA neither showed polysaccharide lyase activity nor exhibited binding to glycosaminoglycans when assessed by isothermal titration calorimetry (ITC), affinity gel electrophoresis and microarray screening [6] . Nevertheless, the hypothesis that PfbA would be a novel type of carbohydrate-specific adhesin was favoured, as the only common feature of the known ligands of PfbA was that, all of them were glycoproteins [6] . The C-terminal domain (571-684) of PfbA starts with two antiparallel beta hairpins with a disordered region (Ile580 to Ser583) in between [7] . Interestingly, as the segment Asn574 to Gly585 exhibits similarity in sequence and structure to the intrinsically disordered Fn-binding regions (FnBRs) of Fn-binding proteins (FnBPs), this region in the C-terminal domain was hypothesized to be the Fn-binding region of PfbA [7] . It was also hypothesized that the unusually abundant surfaceexposed lysines of the beta helix would help PfbA to bind plasminogen (Plg) as seen in many other Plgbinding proteins [7] .
This study focuses on verifying these hypotheses regarding the mode of binding of PfbA to the different host protein ligands. Since the beta helix and the region following it are found to be independent domains or modules, these regions were cloned separately (Fig. 1B,C) and analysed for binding to the ligands (Fn, Plg and HSA) of PfbA. The C-terminal region was checked for binding to Fn and also in particular, to the N-terminal region of Fn (Fn-F). It was also tested if PfbA's lysines were involved in its interaction with Plg. Furthermore, a conserved metalbinding site common to polysaccharide lyases was also found in PfbA, occupied by metal atoms [7] , inciting further investigations in the binding of PfbA to carbohydrates. Since only activity on polysaccharides and binding to glycosaminoglycans were monitored earlier [6] , PfbA's binding to monosaccharides, a disaccharide and a trisaccharide was probed alternately. The outcome of these investigations shows that PfbA indeed has modules or domains that are independent not only structurally but also functionally. And importantly, our study further revealed that PfbA can also recognize carbohydrates which could be crucial for colonizing the host.
Results
PfbA binds to Fn-F rPfbA 49-684 is known to bind to Fn, Plg and HSA as described previously [5] . To narrow down the ligandbinding region and to find out the ligand-binding properties of the different modules of PfbA, binding studies using ELISA were done to check the interaction of the rPfbA constructs: rPfbA 49-684 , rPfbA 150-607 , rPfbA 150-570 and rPfbA (Fig. 1C) with Fn, Plg and HSA. ELISA with the 30 kDa N-terminal fragment of Fn, termed as Fn-Fragment or Fn-F which is free of carbohydrate moieties, was also carried out to see if PfbA interacts exclusively with the F1 modules of Fn. The ELISA results showed that all rPfbA-host protein bindings are concentration-dependent and the maximum binding is observed at an rPfbA concentration of around 0.5-2 lM ( Fig. 2A-D) . In all the assays done, the negative control rErpX [8] , showed only negligible binding to the ligands when compared to the rPfbA samples ( Fig. 2A-F) .
ELISA results showed significant binding of rPfbA with Fn-F. Moreover, rPfbA 150-607 which is the portion of PfbA that was crystallized could also bind to Fn, Plg HSA as well as Fn-F ( Fig. 2A-F ) equivalent to rPfbA . Therefore, it is more likely for this central part with 458 residues to have all the ligand-binding sites and it is unlikely for the N-terminal region (the a/b cap domain [6] ) of PfbA to be involved in ligand binding. Binding affinities of rPfbA , rPfbA 150-570 and rPfbA 571-684 towards Fn, Fn-F, Plg and HSA were calculated by BLI using the 1 : 1 binding model.
PfbA's beta helix and the C-terminal region can bind to Fn independently
The results of the binding studies by ELISA also showed that like the full-length PfbA (rPfbA ), the other three constructs (rPfbA 150-607 , rPfbA 150-570 and rPfbA ) are able to interact and bind to Fn significantly ( Fig. 2A,E) . This shows that PfbA has Fnbinding regions in both its central beta helix as well as its C-terminal region. The binding affinities of rPfbA All bindings observed in ELISA and BLI experiments are statistically significant when checked using Student's t-test. The significant difference in the binding of the rPfbA constructs to the ligands in comparison with rErpX for a representative concentration of 2 lM in ELISA is indicated by asterisks in a bar diagram (Fig. 2E) . The binding profile of all the constructs and ErpX is given as a table in Fig. 2F . Also, the BLI experiments demonstrate that PfbA's affinities for Fn, Plg and HSA are found to range from nanomolar to micromolar scale, with the highest affinity being towards Fn followed by Plg and then to HSA. This order also ascertains the previous findings by Yamaguchi et al. [5] . The kinetic rate constants for all interactions between the different rPfbA constructs and the host proteins are presented in Table 1 and the corresponding BLI response curves of the interactions in Figs 3 and 4.
PfbA binds to carbohydrates
PfbA was predicted to belong to the group of proteins having the beta-helical structure [5] . Later by the determination of the crystal structure of rPfbA 150-607 , it has been proved that its central region consists of a right-handed beta-helical structure as expected [6, 7] . PfbA was also annotated to be a carbohydrate-modifying enzyme [5] and the structure of PfbA shows that the parallel beta helix region has a prominent groove running along its length similar to that found in polysaccharide lyases [6] . This structural similarity with carbohydrate-modifying proteins supports the hypothesis that PfbA would be a part of a novel family of carbohydrate-specific adhesins [6] . Therefore, to find if PfbA could recognize sugars, ITC experiments were carried out where rPfbA 49-684 was titrated with monosaccharides: D-galactose, D-mannose, N-acetylneuraminic acid (Neu5Ac), D-glucosamine and D-galactosamine, a disaccharide: D-sucrose and a trisaccharide: D-raffinose. In these experiments, it was observed that rPfbA binds to each of these tested saccharides.
The results of the ITC experiments are presented in Figs 5 and 6. These results reveal that the binding reactions between rPfbA 49-684 and the sugars are energetically favourable and hence spontaneous. Further, all the titration curves gave the best fit with n = 2 indicating two binding sites on the protein for the sugar. The shape of the thermograms shows that 
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The FEBS Journal 284 (2017) 3404-3421 ª 2017 Federation of European Biochemical Societies the two binding processes overlap [9] (Figs 5 and 6). The binding of all the monosaccharides and the disaccharide to PfbA in both sites is enthalpydriven, as the contribution of entropy towards the binding energy is much less compared to that of enthalpy. This also reveals that the bound sugar is stabilized by hydrogen bonds and van der Waals forces [10] . Raffinose, the trisaccharide is also seen to interact with PfbA in two sites. While the binding to the first site is enthalpy-driven similar to that of the other sugars, binding to the second site is driven by entropy. This indicates that raffinose in the first binding site is stabilized by hydrophilic interactions while that in the second site is stabilized by hydrophobic interactions.
As all the bindings are enthalpy-driven, │DH│ is greater than │TDS│ in all the cases, except for the binding of D-raffinose to the second site. These results indicate that PfbA interacts and binds to sugars mainly through electrostatic and hydrogen bonds as well as through van der Waals contacts with a few hydrophobic interactions. The binding affinities between rPfbA 49-684 and the different sugars are presented in Table 2 .
PfbA also binds to fibrinogen, laminin and collagen type IV On account of PfbA's binding to carbohydrates and that all its known ligands are glycoproteins, the theory presuming that PfbA recognized a glycan decoration present on these glycoconjugates [6] was contemplated. Accordingly, rPfbA 49-684 , rPfbA 150-570 and rPfbA were allowed to interact with additional ECM proteins like human fibrinogen (Fg) (Sigma Aldrich Chemicals Pvt Ltd, Bangalore, India), human laminin (Sigma Aldrich Chemicals Pvt Ltd) and human collagen type IV (Sigma Aldrich Chemicals Pvt Ltd) and binding kinetics were analysed by BLI (Fig. 7) . The results of the BLI assays concluded that rPfbA 49-684 and rPfbA are able to bind significantly to Fg, laminin and collagen type IV with relatively high affinities and that rPfbA (Fig. 8B) . Similarly, when rPfbA 49-684 was incubated with 20 mM D-galactose and used in the BLI experiments, its binding affinity towards the host protein ligands is reduced (Table 3 ). This reduction in affinity is found to be seen with rPfbA 150-570 incubated with 20 mM D-galactose as well. The reductions are statistically significant when checked by Student's t-test. These results together prove that the beta helix module of PfbA recognizes and binds to the glycan part of its different glycoprotein ligands.
Lysines are not responsible for PfbA's binding to Plg
Many Plg-binding proteins interact with Plg through their lysine residues [11] . PfbA has an unusually high number of surface-exposed lysines in its beta helix region and this led to the hypothesis that PfbA, like the other Plg-binding proteins could make use of its lysines to bind to Plg [7] . In order to test this, the lysines of rPfbA 49-684 were modified and blocked by succinylation. ELISA experiment to check Plg binding was carried out where the succinylated-rPfbA 49-684 was used in the place of the native rPfbA 49-684. Here, the succinylated-PfbA was expected to show reduced or no interaction with Plg. However, there was no significant difference between the interactions of native and succinylated-PfbA with Plg (Fig. 9 ). To confirm this behaviour, ELISA experiments done using 50 mM of the lysine analogue, e-aminocaproic acid (EACA) along with Plg, showed that EACA did not inhibit the binding of rPfbA with Plg significantly (Fig. 9) . BLI experiments also show that the affinity of succinylated-rPfbA 49-684 towards Plg (K D = 5.372 9 10
did not differ significantly from that of native rPfbA 49-684 towards Plg (K D = 4.206 9 10 À6 M). Thus, though the Plg-binding region in PfbA was found to be the beta helix, it is evident that its lysine residues may not be involved in the binding and thus PfbA binds to either only the glycans of Plg or through some other unknown mechanism.
Discussion
The epithelium and the mucous layer of the human airway and lungs are heavily glycosylated with surface carbohydrates. For attachment to and colonization of the human host, many respiratory pathogens therefore target these diverse sugar structures that include N-linked and O-linked glycans as well as glycosaminoglycans [12] [13] [14] . Infection of the host by pathogens is one of the many processes that critically depend on protein-carbohydrate interactions [15] , where carbohydrates serve as receptors for infection [16] . The major respiratory pathogen S. pneumoniae also employs many carbohydrate-recognizing proteins that are exposed on its surface to adhere, invade and modify the immune responses of the host [14] . The results of the present study show PfbA to be a carbohydrate-binding surface protein of S. pneumoniae, with its central elongated and rod-like beta-helical domain being the carbohydrate-recognizing region. This beta helix made of 422 residues with ten complete coils of the beta-structure, is also the largest and the predominant structural motif of PfbA. Its conventional righthanded parallel beta-helical topology or the pectate lyase scaffold is a common and characteristic feature of viral, bacterial, fungal and plant enzymes that are mostly lyases and hydrolases, degrading or modifying acidic polysaccharides [17, 18] . The main structural homologues of PfbA are the tail-spike proteins of bacteriophages. Other similar proteins are polygalacturonases of bacteria and fungi that are mostly plant pathogens. Though many human bacterial pathogens have been predicted to have proteins with the parallel beta helix [19] , this fold is rare among the Streptococci. Since genes from bacteriophages can be acquired by bacteria through lateral gene transfer by transduction [20] , it is therefore likely for S. pneumoniae to have acquired this fold only from the tail-spike genes of bacteriophages that infected them. Like its homologues, the beta helix of PfbA is made of three parallel beta sheets PB1, PB2 and PB3 and has a channel-like groove or cleft made of extensions of turns T1 and T3 and PB1 running along the length of its surface [6, 7] . This groove bears the sugar-recognizing region and active site in almost all the beta-helical proteins. In PfbA, the side chains of several positively charged residues, a few negatively charged ones as well as many polar residues protrude into the groove, making it favourable for binding to carbohydrates. Among these residues, there are seven aromatic ones whose side chain rings can stack against the pyranose-ring structures of the saccharides [21] .
It can be seen in the crystal structure of PfbA , that the groove from the N-terminal region till the centre of the helix is narrower, while the rest of the groove becomes wider till the end of the helix (Fig. 10) . The N-terminal end of the groove is blind and sealed off by the initial T1 and T3 turns of the molecule like in the case of a homologous protein, exopolygalacturonase, YeGH28 of Yersinia enterocolitica (PDB id: 2UVE). This blind end of the groove makes PfbA capable of binding only to external portions of oligosaccharides through this region and sterically prevents it from binding internal residues of the sugars, like in YeGH28 [22] . Moreover, in the N-terminal region of the groove, the spatial arrangement of its residues His304, Gln307, Gln342, Tyr353 and His388 is similar to that of the sugar-binding residues corresponding to His196, Asn199, Gln225, Tyr149 and Lys255 of another homologous protein mannuronan-C5-epimerase, AlgE4A of Azotobacter vinelandii (PDB id: 2PYG) [18] (Fig. 11) . Also, in the structure of rPfbA 150-607 [7] , the residues His304, Gln307, Gln342, Glu344, Tyr353 and His388 are coordinated with two metal (Mn) atoms in the groove region. In the structure in complex with sugar of tail-spike protein of the Escherichia coli bacteriophage HK620, another homologous protein (PDB id: 2VJJ), two metal ions (Ca and K) are present in the groove region. These are in complex with the rhamnose unit in the reducing end of the hexasaccharide bound to the groove [23] . This implies the possibility of PfbA binding to sugars in the groove along with the metal atoms [24] (Fig. 12A,B) . The second part of the groove is characterized by a regular arrangement of floor residues distending from PB1, viz., Arg416, Asn450, Arg485 and Glu520. These are flanked on the sides by Tyr412, Arg442, Tyr452, Lys482, Asp489, Arg523, Glu540 and Glu545. This region looks ideal for binding to trisaccharides like as in the case of AlgE4A (PDB id: 2PYH) [18] (Fig. 12C,D) , or to longer as well as branched oligosaccharides [6] . Though the arrangement of a few of the groove residues in PfbA is similar to some of the sugar-binding sites of the CAZymes, it does not resemble any of the catalytic assembly of the lyases or hydrolases, indicating that PfbA unlike its homologues is more likely to be a carbohydrate-binding adhesin than an enzyme. In the ITC experiments that were carried out, it is seen that PfbA binds to all of the tested saccharides, and does not display specificity to any particular sugar among them. In fact, PfbA binds to all of the different monosaccharides: the two hexose-epimers of glucose (galactose and mannose), the two amino sugars (glucosamine and galactosamine) and the one with the nine-carbon backbone having the aminoacetyl group (Neu5Ac). It also binds to the disaccharide and the trisaccharide. However, though all of these bindings are mainly driven by enthalpy, their thermodynamic profiles vary, indicating that different modes and residues of binding are possible. This is further demonstrated by the difference between PfbA's-binding ability to raffinose (which is made of galactose, glucose and fructose), galactose and sucrose (that has glucose and fructose) individually. Thus, the distribution and structural arrangement of the groove residues in the beta helix of PfbA is responsible for its binding to different types of carbohydrates.
PfbA can therefore target the oligosaccharides present in the mucous layer of the human nasopharynx and lungs. In addition, PfbA can also bind to oligosaccharides attached to glycosylated macromolecules like glycoproteins and glycolipids that are present on the epithelial surface and in the ECM, through its beta helix. Mucin, the major component of the mucous layer is a heavily glycosylated protein [25] . Its O-linked glycans which are linear or branched oligosaccharides made of up to 20 sugar residues, start with an N-acetyl galactosamine (GalNAc) and terminate with fucose, galactose, GalNAc or Neu5Ac residues [25] . The respiratory ECM consist of a polysaccharide gel having glycosaminoglycans in which fibrous proteins like collagen and adhesive proteins like Fn and laminin are embedded [26] . Branched biantennary and triantennary oligosaccharides made of sugar residues like galactose, glucose, fucose, GalNAc, N-acetyl glucosamine (GluNAc), mannose and Neu5Ac are seen in these ECM proteins as well as in proteins like Plg and Fg that are present in the ECM and blood [27] [28] [29] [30] [31] . The pattern of glycosylation as well as the saccharides present is similar in all these glycoproteins [27] [28] [29] [30] [31] . Further, the hinge region of immunoglobulin A (IgA) molecules present in the human airway is also decorated by similar glycans [32] . In all these molecules, Neu5Ac is seen to be in the terminal positions. PfbA's beta helix can therefore bind to Neu5Ac or to other underlying sugars like galactose and mannose when the terminal Neu5Ac residues are removed by glycosidases of S. pneumoniae like neuraminidase (NanA) and O-glycosidase [13] . HSA, one of PfbA's ligands however does not have the branched oligosaccharides of the ECM glycoproteins, but is glycosylated with glucose residues [33] which can be recognized by PfbA.
The C-terminal region of PfbA from residues 571 to 684 is shown to bind only to Fn and Fn-F which is devoid of sugar. This region is seen to be a structurally and functionally specific region exclusive for Fn binding. Since, this region binds to the N-terminal F1 modules of Fn, it is likely through the beta-zipper mechanism as previously hypothesized [7] . Moreover, both regions of PfbA [the beta helix (residues 150-570) and the C-terminal region (571-684)] can bind to Fn simultaneously, strengthening the interaction. Thus, PfbA the surface adhesin of S. pneumoniae, is a multidomain protein composed of three domains or modules: the N-terminal domain, the central beta helix module and the C-terminal region. While the role of the N-terminal domain remains to be determined, both the central module and the C-terminal region target Fn, however through different mechanisms, making PfbA essentially a Fn-adhesin. The function of PfbA is further broadened by the beta helix module that can nonspecifically, yet strongly bind to the oligosaccharide glycans of different glycoproteins.
Experimental procedures
Cloning, expression and purification of rPfbA constructs: rPfbA 150-607, rPfbA 150-570 and rPfbA PfbA (strain R6) made of 719 amino acids consists of three parts: (a) the N-terminal signal peptide (residues 1-48), (b) the central region, which is the putative ligand-binding part (residues 49-684) and (c) the rear cell wall-anchoring region (residues 685-719), which includes the sortase-recognising LPKTG motif, a hydrophobic membrane-spanning domain and a short terminal charged tail (Fig. 1A) . Previously, the structural studies on PfbA were initiated using the clone rPfbA , consisting of the central ligand-binding region [7] . However, a segment consisting of only residues from 150 to 607 was crystallized and the structure of rPfbA 150-607 was solved (PDB id: 4MR0) [7] . Based on this structure, for the present study, three new recombinant constructs of rPfbA were prepared. The first one rPfbA 150-607, has residues from Thr150 to Asn607 representing the region of PfbA seen in the crystal structure. The second construct rPfbA , from Thr150 to Lys570 is composed of the beta helix module alone. The third is rPfbA 571-684 , with residues Ser571 to Lys684, representing the C-terminal region of PfbA. All constructs were cloned in pQE-30 vector (Qiagen, Venlo, the Netherlands) and the recombinant plasmids were incorporated into E. coli BL21(DE3) pLysS cells (Novagen, Madison, WI, USA). All the three recombinant PfbA proteins were purified by nickel-affinity chromatography followed by gel-filtration chromatography with procedures similar to those followed for the purification of rPfbA 49-684 previously [7] . The purified proteins had Deglycosylation of ECM protein, fibrinogen (Fg) 0.1 lM of human fibrinogen (Sigma Aldrich Chemicals Pvt Ltd) was mixed with 5-10 units of the enzyme PNGase F (N-Glycosidase F from New England Biolabs, Ipswich, MA, USA) and the reaction mixture was made up to 10 lL with sodium phosphate buffer, pH 7.4. For enzyme activation, the mixture was incubated at 37°C for 10-15 h. The cleaved oligosaccharides of Fg that have a molecular weight of 2 kDa, were separated from it by centrifuging the protein in a spin column (QIAprep; Qiagen) having 9 kDa molecular weight cutoff membrane. The deglycosylated-Fg was then separated from nondeglycosylated molecules (native-Fg) by ion-exchange chromatography and the samples were analysed by native PAGE and SDS/PAGE.
Western blot analysis of rPfbA 49-684 binding to deglycosylated-Fg rPfbA was first run at 100 V, on two lanes of a 10% SDS/PAGE gel and then electroblotted at 15 V for 15 min, onto a PVDF membrane, previously equilibrated in Towbin's buffer, pH 8.3. The blotted membrane was then blocked o/n with TBST (Tris buffered saline with 1% Tween 20) having 3% BSA. After blocking, the membrane was cut into two parts, each containing a sample of rPfbA . One part was incubated with 1 lM native human Fg (Sigma Aldrich Chemicals Pvt Ltd) and the second part with the same amount of the prepared deglycosylated-Fg for 1 h at RT. The membranes were further incubated with mouse monoclonal anti-Fg antibody (Sigma Aldrich Chemicals Pvt Ltd), diluted 1 : 10 000 in TBST for 1 h at RT, followed by incubation with goat alkaline phosphatase-conjugated anti-mouse IgG secondary antibody (Calbiochem) diluted 1 : 5000 in TBST for 1 h at RT. The membranes were washed three times with TBST in between all the above-mentioned steps. Binding of the secondary antibody was probed by adding the substrates, 5-bromo, 4-chloro, 3-indolyl phosphate disodium salt (BCIP; 1 mL of 1% BCIP in 100% dimethylformamide) and nitroblue tetrazolium choride (NBT; 1 mL of 1.5% NBT in 70% dimethylformamide) in TBST. This was followed by adding a developing solution (100 mM Tris-HCl, pH 9.5, with 1 mM MgCl 2 ) to the membranes and incubating for 30 min in dark. Interaction between PfbA and Fg was visualized as blue-purple bands corresponding to the rPfbA bands blotted to the membrane.
Succinylation of rPfbA 49-684
Succinylation of rPfbA was carried out to modify specifically its lysine residues, by attaching a succinyl group to the e-amino group of each lysine and thereby blocking them. The procedure described by Habibi et al. was followed [34] . A 5 mgÁmL À1 solution of rPfbA in 100 mM borate buffer, pH 8.0, was taken. Succinic anhydride (SA) was added in steps to the protein solution at regular intervals with stirring at 4°C. Four milligram of the anhydride was added during each step till the anhydride was present in more than 50-fold excess over the protein. The pH of the solution was maintained at 8.0 by adding NaOH. The degree of lysine modification upon each addition of SA was checked by trinitrobenzene sulphonic acid (TNBS) assay [35] and the amount of SA to be added for the succinylation of all the lysines was determined. Thus, all the lysines of rPfbA 49-684 were succinylated by using the required amount of SA.
Statistical analyses
The ELISA and BLI experiments described were carried out in four and three independent experiments respectively. For ELISA, the mean and standard deviation values were calculated and the graphs were made using Microsoft Excel Ò . Statistical analyses were carried out using Student's t-test with GRAPHPAD software (GraphPad Software Inc., La Jolla, CA, USA), with P values less than 0.05 regarded statistically significant.
